Down 99%, biotech firm 180 Life Sciences pivots to crypto with ETH bet

The Nasdaq-listed biotechnology firm is raising $425 million for its ETH strategy, joining a parade of penny stocks investing in cryptocurrencies as their business flounders.

Related Posts

Leave a Reply

Recent Articles

Bitcoin whale reveals 3.5K BTC short: Key support levels to watch next
October 14, 2025
Price predictions 10/13: SPX, DXY, BTC, ETH, BNB, XRP, SOL, DOGE, ADA, HYPE
October 14, 2025
Nobel Peace Prize bets on Polymarket under scrutiny: Report
October 14, 2025

Text Widget

Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.

Post Category